Latest Moxi Stories
Patent-pending ophthalmic formulation revenues increased over 190% compared to the second quarter 2014 SAN DIEGO, Nov. 12, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc.
SUWANEE, Ga., July 23, 2014 /PRNewswire/ -- ARRIS Group, Inc. (NASDAQ: ARRS) announced that
Binge-viewing, second-screen purchasing, DVR usage, and multiscreen/room consumption on the rise--tracking consumer demand for entertainment anytime, anywhere, on any device, and in any amount SUWANEE,
Intelligent, refined hearing instrument gains further international recognition for product design excellence KITCHENER, Ontario, March 24, 2014 /PRNewswire/ -- Unitron, a
Refined and intelligent design puts Unitron hearing instrument on the world stage KITCHENER, Ontario, Feb.
Take the guesswork out of setup and maintenance of advanced therapeutic support surfaces with MOXI's iSense processing and auto comfort (TM). St.
- totally perplexed and mixed up.